【24h】

Photodynamic therapy and fluorescent diagnostics of breast cancer metastases with photosense and alasense

机译:光学动力治疗和乳腺癌转移荧光诊断与光素和别美的乳腺癌转移

获取原文

摘要

Photodynamic Therapy (PDT) and fluorescent diagnostics (FD) using photosensitizers Photosense (Aluminium Phtalocyanine, (NIOPIC, Russia) (PS) and Alasense have been provided in 101 patients with breast cancer as a multicenter study. All patients had recurrences of breast cancer (skin metastases)after combined treatment, chemotherapy and radiotherapy. FD of tumor with detecting of subclinical sites, accumulation of PS in tumor, adjacent tissue, skin before and during PDT was fulfilled. Multiple surface irradiations were carried on with interval 24-72 hours (semiconductive laser -λ = 672 + 2nm) in light dose 100J/cm~2 and total light dose 300-900 J/cm~2. 2 months after PDT we had overall response rate of 86,87% with complete response (CR) in 51,48% and partial response in 35,39%. During year after PDT in 52 patients with CR we had CR in 36.6%, local recurrences in 23,1%, progression (distant (lung or bone) metastasis) in 40,4% of cases. Our experience show pronounced efficacy of PDT for skin metastases of breast cancer.
机译:使用光敏剂的光动力疗法(PDT)和荧光诊断(FD)使用光敏剂的光电(磷酸铝,俄罗斯(牛仔苷,俄罗斯)(PS)和己二es,作为多中心的研究。所有患者患有乳腺癌的复发(皮肤转移组合治疗,化疗和放疗后。肿瘤检测患者的肿瘤FD,肿瘤中PS累积,PDT之前和在PDT之前和期间的皮肤。间隔24-72小时进行多种表面照射(光剂量100J / cm〜2的半导体激光-λ= 672 + 2nm&总光剂量300-900 J / cm〜2。PDT后2个月,我们的整体反应率为86,87%,完全反应(CR) 51,48%和部分反应35,39%。在52例CR患者的PDT期间,我们在36.6%,局部复发中患有33,1%,进展(遥远(肺或骨)转移)的患者,4%的病例。我们的经验显示了PDT的发音效果乳腺癌皮肤转移。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号